Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 49,459 | 29,222 | 26,488 | 32,183 | 29,204 |
| Cost of Goods | 13,654 | 10,677 | 7,786 | 11,611 | 7,550 |
| Gross Profit | 35,805 | 18,545 | 18,702 | 20,572 | 21,654 |
| Operating Expenses | 24,981 | 27,257 | 32,721 | 34,657 | 25,252 |
| Operating Income | 11,478 | -8,035 | -13,233 | -13,474 | -3,048 |
| Interest Expense | 770 | 768 | 765 | 763 | 761 |
| Other Income | 690 | -7,493 | 702 | 3,488 | 932 |
| Pre-tax Income | 11,398 | -16,296 | -13,296 | -10,749 | -2,877 |
| Income Tax | -47 | 56 | 245 | -273 | 44 |
| Net Income Continuous | 11,445 | -16,352 | -13,541 | -10,476 | -2,921 |
| Net Income | $11,445 | $-16,352 | $-13,541 | $-10,476 | $-2,921 |
| EPS Basic Total Ops | 0.12 | -0.17 | -0.14 | -0.11 | -0.03 |
| EPS Basic Continuous Ops | 0.12 | -0.17 | -0.14 | -0.11 | -0.03 |
| EPS Diluted Total Ops | 0.11 | -0.17 | -0.14 | -0.11 | -0.03 |
| EPS Diluted Continuous Ops | 0.11 | -0.17 | -0.14 | -0.11 | -0.03 |
| EPS Diluted Before Non-Recurring Items | 0.11 | -0.17 | -0.14 | -0.11 | -0.03 |
| EBITDA(a) | $17,272 | $1,350 | $-3,849 | $-6,112 | $3,236 |